Grant & Eisenhofer helped lead litigation resulting in a $775 million settlement for patients injured by Xarelto
Plaintiff(s):
Individuals
Case type / claims:
Complex mass tort and product liability action alleging that Bayer and Janssen failed to adequately warn patients and physicians about the risk of severe bleeding associated with Xarelto use.
Defendant(s):
Bayer HealthCare Pharmaceuticals Inc. and Janssen Pharmaceuticals, Inc.
Jurisdiction:
U.S. District Court for the Eastern District of Louisiana
Year:
2019
Outcome:
- $775 million settlement resolving thousands of lawsuits nationwide.
- G&E principal Elizabeth Graham served in leadership on the Plaintiffs’ Steering Committee.
